Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2024-04-23 AGM Information
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
Convening Notice (ENG).pdf
AGM Information Classification · 99% confidence The document is explicitly titled 'INVITATION ORDINARY AND EXTRAORDINARY GENERAL SHAREHOLDERS' MEETINGS' and details the agenda, proposed resolutions, dates (May 23, 2024), and location for these meetings. This content directly corresponds to the materials presented or proposed for discussion at an Annual General Meeting (AGM). Although it mentions reports (like the annual report for 2023), the primary purpose of this document is to convene the shareholders and outline the voting items, making it an AGM-related document. The code 'AGM-R' (AGM Information) is the most appropriate classification.
2024-04-23 English
Convening Notice (DUT).pdf
AGM Information Classification · 99% confidence The document is explicitly titled 'UITNODIGING GEWONE EN BUITENGEWONE ALGEMENE AANDEELHOUDERSVERGADERINGEN' (Invitation to Ordinary and Extraordinary General Shareholders' Meetings) and details the agenda, including voting on annual accounts, director remuneration, auditor reappointment, and specific corporate actions related to convertible loans. This content is the core material distributed to shareholders in advance of a General Meeting to inform their vote. This directly corresponds to the definition of materials shared during an Annual General Meeting (AGM). The code AGM-R (AGM Information) is the most appropriate classification, as opposed to DEF 14A (Remuneration Information) or PSI (Proxy Solicitation), because it covers the entire scope of the meeting, not just one aspect or the solicitation itself, and it is the primary document for the AGM proceedings.
2024-04-23 Dutch
20240418_Annual Report 2023_combined_ENG vF.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2023' and contains a comprehensive table of contents covering strategy, business achievements, corporate governance, and detailed financial statements (Income Statement, Balance Sheet, Cash Flows, etc.). It is a full-year report for the fiscal year 2023, fitting the definition of a 10-K (Annual Report). FY 2023
2024-04-23 English
Press Release_AGM EGM Notice 23 April 2024_NL_vF.pdf
AGM Information Classification · 98% confidence The document is a press release dated April 23, 2024, announcing two key items: 1) The scheduling of the Annual and Extraordinary General Shareholders' Meetings (AGM/EGM) for May 23, 2024. 2) The publication of the 2023 Annual Report. The text details the agenda items for the meeting, which include approving resolutions related to the fiscal year ended December 31, 2023, and a significant capital increase via in-kind contribution (debt-to-equity swap). Since the primary focus is the announcement of the upcoming General Meeting and its agenda, the most fitting primary classification is AGM-R (AGM Information). Although it mentions the publication of the Annual Report, the document itself is the announcement/invitation, not the full 10-K report. The detailed discussion of related party transactions and the auditor's review of the board's proposal regarding the capital increase strongly support the AGM context.
2024-04-23 Dutch
Press Release_AGM EGM Notice 23 April 2024_ENG_vF.pdf
AGM Information Classification · 98% confidence The document is titled "Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024" and explicitly mentions the "Publication of Annual Report 2023". It details the agenda for the AGM, which includes resolutions related to the financial year ended 31 December 2023, remuneration policy, and capital increases. The document is a press release dated April 23, 2024, announcing these meetings and the availability of the Annual Report. Since it is an announcement about the upcoming AGM and the publication of reports, and it contains detailed information about shareholder votes and related corporate governance matters (like the contribution in kind requiring independent director advice), it strongly relates to the AGM process. The primary focus is the invitation to the AGM and the associated resolutions. Therefore, AGM-R (AGM Information) is the most appropriate classification, although RPA (Report Publication Announcement) is also relevant due to the mention of the Annual Report publication. Given the comprehensive nature of the AGM agenda and related corporate actions described, AGM-R takes precedence over a simple RPA.
2024-04-23 English
20240418_Annual Report 2023_combined_NL vF.pdf
Annual Report Classification · 100% confidence The document is titled 'JAARVERSLAG 2023' (Annual Report 2023) for Sequana Medical. It contains a comprehensive structure including strategy, business achievements, corporate governance, and a detailed 'FINANCIEEL RAPPORT' (Financial Report) section with consolidated financial statements (balance sheet, income statement, cash flow, etc.). As it is the full annual report containing audited financial statements, it is classified as a 10-K (Annual Report). FY 2023
2024-04-23 Dutch

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.